OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
16.94
-0.39 (-2.25%)
Aug 14, 2025, 9:23 AM - Market open
OptimizeRx Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 104.75 | 92.13 | 71.52 | 62.45 | 61.29 | 43.31 | Upgrade
|
| Revenue Growth (YoY) | 25.89% | 28.81% | 14.53% | 1.89% | 41.51% | 76.08% | Upgrade
|
| Cost of Revenue | 37.3 | 32.75 | 28.62 | 23.48 | 25.65 | 19.21 | Upgrade
|
| Gross Profit | 67.45 | 59.38 | 42.9 | 38.97 | 35.64 | 24.11 | Upgrade
|
| Selling, General & Admin | 47.99 | 49.8 | 40.03 | 33.49 | 27.7 | 20.18 | Upgrade
|
| Operating Expenses | 63.81 | 65.6 | 56.15 | 51.26 | 35.28 | 25.43 | Upgrade
|
| Operating Income | 3.64 | -6.22 | -13.25 | -12.29 | 0.36 | -1.32 | Upgrade
|
| Interest Expense | -5.99 | -6.16 | -1.45 | - | - | - | Upgrade
|
| Interest & Investment Income | 0.38 | 0.33 | 2.19 | 0.85 | 0.02 | 0.07 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.15 | 0.15 | 0.5 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -1.82 | -11.9 | -12.01 | -11.44 | 0.38 | -1.26 | Upgrade
|
| Merger & Restructuring Charges | - | - | -4.27 | - | - | -0.81 | Upgrade
|
| Impairment of Goodwill | -7.49 | -7.49 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -2.14 | - | - | - | Upgrade
|
| Asset Writedown | - | - | -6.74 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | - | -0.14 | Upgrade
|
| Pretax Income | -9.3 | -19.39 | -25.16 | -11.44 | 0.38 | -2.21 | Upgrade
|
| Income Tax Expense | 0.57 | 0.73 | -7.6 | - | - | - | Upgrade
|
| Net Income | -9.87 | -20.11 | -17.57 | -11.44 | 0.38 | -2.21 | Upgrade
|
| Net Income to Common | -9.87 | -20.11 | -17.57 | -11.44 | 0.38 | -2.21 | Upgrade
|
| Shares Outstanding (Basic) | 18 | 18 | 17 | 18 | 17 | 15 | Upgrade
|
| Shares Outstanding (Diluted) | 18 | 18 | 17 | 18 | 18 | 15 | Upgrade
|
| Shares Change (YoY) | 4.07% | 6.82% | -3.71% | 0.53% | 19.30% | 10.76% | Upgrade
|
| EPS (Basic) | -0.54 | -1.10 | -1.03 | -0.64 | 0.02 | -0.15 | Upgrade
|
| EPS (Diluted) | -0.54 | -1.10 | -1.03 | -0.64 | 0.02 | -0.15 | Upgrade
|
| Free Cash Flow | 10.34 | 4.78 | -7.33 | 10.57 | 0.63 | -6.38 | Upgrade
|
| Free Cash Flow Per Share | 0.56 | 0.26 | -0.43 | 0.59 | 0.04 | -0.43 | Upgrade
|
| Gross Margin | 64.39% | 64.45% | 59.98% | 62.40% | 58.14% | 55.65% | Upgrade
|
| Operating Margin | 3.47% | -6.75% | -18.53% | -19.68% | 0.59% | -3.06% | Upgrade
|
| Profit Margin | -9.42% | -21.83% | -24.56% | -18.32% | 0.62% | -5.10% | Upgrade
|
| Free Cash Flow Margin | 9.87% | 5.18% | -10.24% | 16.93% | 1.02% | -14.73% | Upgrade
|
| EBITDA | 7.96 | -1.89 | -10.85 | -10.27 | 2.33 | 0.65 | Upgrade
|
| EBITDA Margin | 7.60% | -2.05% | -15.17% | -16.44% | 3.80% | 1.49% | Upgrade
|
| D&A For EBITDA | 4.33 | 4.33 | 2.4 | 2.02 | 1.97 | 1.97 | Upgrade
|
| EBIT | 3.64 | -6.22 | -13.25 | -12.29 | 0.36 | -1.32 | Upgrade
|
| EBIT Margin | 3.47% | -6.75% | -18.53% | -19.68% | 0.59% | -3.06% | Upgrade
|
| Advertising Expenses | - | 1.05 | 0.78 | - | - | 0.62 | Upgrade
|
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.